The influence of highly effective modulator therapies on the sputum proteome in cystic fibrosis
View ORCID ProfileRosemary E Maher, View ORCID ProfilePeter J Barry, View ORCID ProfileEdward Emmott, Andrew M Jones, View ORCID ProfileLijing Lin, View ORCID ProfilePaul S McNamara, View ORCID ProfileJaclyn A Smith, View ORCID ProfileRobert W Lord
doi: https://doi.org/10.1101/2023.04.17.23288625
Rosemary E Maher
1Centre for Proteome Research, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK
Peter J Barry
2Manchester Adult CF Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester M23 9LT
Edward Emmott
1Centre for Proteome Research, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK
Andrew M Jones
2Manchester Adult CF Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester M23 9LT
3Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, M13 9PL
Lijing Lin
4Faculty of Biology, Medicine and Health, University of Manchester, M13 9PL
Paul S McNamara
5Department of Child Health (University of Liverpool), Institute in the Park, Alder Hey Children’s Hospital, Eaton Rd, Liverpool, L12 2AP
Jaclyn A Smith
3Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, M13 9PL
6Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester M23 9LT
Robert W Lord
2Manchester Adult CF Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester M23 9LT
3Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, M13 9PL
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted April 24, 2023.
The influence of highly effective modulator therapies on the sputum proteome in cystic fibrosis
Rosemary E Maher, Peter J Barry, Edward Emmott, Andrew M Jones, Lijing Lin, Paul S McNamara, Jaclyn A Smith, Robert W Lord
medRxiv 2023.04.17.23288625; doi: https://doi.org/10.1101/2023.04.17.23288625
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (195)
- Cardiovascular Medicine (2874)
- Dermatology (244)
- Emergency Medicine (432)
- Epidemiology (12597)
- Forensic Medicine (10)
- Gastroenterology (809)
- Genetic and Genomic Medicine (4470)
- Geriatric Medicine (405)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1056)
- Hematology (378)
- HIV/AIDS (905)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4226)
- Nursing (226)
- Nutrition (619)
- Oncology (2216)
- Ophthalmology (629)
- Orthopedics (255)
- Otolaryngology (321)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1181)
- Primary Care Research (485)
- Public and Global Health (6810)
- Radiology and Imaging (1499)
- Respiratory Medicine (904)
- Rheumatology (430)
- Sports Medicine (372)
- Surgery (474)
- Toxicology (59)
- Transplantation (204)
- Urology (175)